Predict your next investment

Venture Capital

See what CB Insights has to offer

Investments

25

About WanWuZiBen Capital

WanWuZiBen Capital is focused on investing in various high-quality blockchain industry projects.

WanWuZiBen Capital Headquarter Location

Beijing, Beijing,

China

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

WanWuZiBen Capital Investments

25 Investments

WanWuZiBen Capital has made 25 investments. Their latest investment was in Wissen Tech as part of their Seed VC - II on June 6, 2022.

CBI Logo

WanWuZiBen Capital Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

6/15/2022

Seed VC - II

Wissen Tech

$10M

No

2

6/14/2022

Series A - II

Boruidi Biotechnology

Yes

2

5/20/2022

Series B

RFGENE

$14.94M

Yes

1

2/28/2022

Series A - II

Subscribe to see more

$99M

Subscribe to see more

10

12/20/2021

Series C

Subscribe to see more

$99M

Subscribe to see more

10

Date

6/15/2022

6/14/2022

5/20/2022

2/28/2022

12/20/2021

Round

Seed VC - II

Series A - II

Series B

Series A - II

Series C

Company

Wissen Tech

Boruidi Biotechnology

RFGENE

Subscribe to see more

Subscribe to see more

Amount

$10M

$14.94M

$99M

$99M

New?

No

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

2

2

1

10

10

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.